Medical management of organophosphate-induced seizures

Journal of Physiology Paris

Volumn 92, Issue 5-6, 1998, Pages 369-373

  Lallement, Guy ^a   Dorandeu, Frédéric ^a   Filliat, Pierre ^a   Carpentier, Pierre ^a   Baille, Valérie ^a   Blanchet, Guy ^b  

^a CENTRE DE RECHERCHES   (France)

^b AST/Bureau Recherches   (France)

Author keywords

Epilepsy; NMDA; Organophosphate; Soman induced seizures

Indexed keywords

BENZODIAZEPINE DERIVATIVE; MUSCARINIC RECEPTOR BLOCKING AGENT; ORGANOPHOSPHATE INSECTICIDE; SOMAN;

BRAIN INJURY; COMPETITIVE INHIBITION; CONFERENCE PAPER; DRUG EFFICACY; DRUG INDUCED DISEASE; EPILEPSY; GABAERGIC TRANSMISSION; HUMAN; INTOXICATION; LUNG FUNCTION; SEIZURE; SYNAPTIC TRANSMISSION;

EID: 0032415051     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(99)80007-2     Document Type: Conference Paper

References (32)

1. [1] Delgado-Escueta et al., N. Engl. J. Med. 306 (1983) 1337-1340.
2. [2] Shih et al., Neurosci. Biobehav. Rev. 15 (1991) 349-362.
3. [3] McDonough et al., NATO RSG III, September, 1995.
4. [4] Dretchen et al., Toxic. Appl. Pharmacol. 83 (1986) 584-589.
5. [5] Carpentier et al., SSA Trav. Sci. 11 (1990) 85-86.
6. [6] Milovanovic et al., IVGoslav. Physiol. Pharmacol. Acta 25 (1989) 99-100.
7. [7] Lallement et al., NeuroToxicology 13 (1992) 557-568.
8. [8] Shih, Psychopharmacol. 78 (1982) 170-175.
9. [9] Lallement et al., Brain Res. 629 (1993) 239-244.
10. [10] Lallement et al., Neurosci. Lett. 139 (1992) 104-107.
11. [11] Denoyer et al., Brain Res. 592 (1992) 157-162.
12. [12] Lallement et al., Brain Res. 563 (1991) 234-240.
13. [13] Lallement et al., NeuroToxicology 12 (1991) 655-664.
14. [14] Lallement et al., Brain Res. 618 (1993) 227-237.
15. [15] McDonough and Shih, Neurosci. Biobehav. Rev. 17 (1993) 203-215.
16. [16] Bodjarian et al., NeuroReport 4 (1993) 1191-1193.
17. [17] Capacio and Shih, Epilepsia 32 (1991) 604-315.
18. [18] Lipp, Electroencephalogr. Clin. Neurophys, 32 (1972) 557-560.
19. [19] Lipp, Arch. Int. Pharmacodyn. 202 (1973) 244-251.
20. [20] Rump et al., Acta Nerv. Super. 14 (1972) 176-177.
21. [21] Rump et al., Neuropharmacology 12 (1973) 813-817.
22. [22] Rump and Grudzinska, Arch. Toxicol. 32 (1974) 223-232.
23. [23] Lundy et al., Arch. Int. Pharmacodyn. 234 (1978) 64-73.
24. [24] Lundy and Shaw, Neuropharmacology 22 (1983) 55-63.
25. [25] Martin et al., Brain Res. 325 (1985) 287-289.
26. [26] Lallement et al., NeuroReport 5 (1994) 425-428.
27. [27] Carpentier et al., NeuroToxicology 15 (1994) 837-852.
28. [28] Braitman and Sparenborg, Brain Res. Bull. 23 (1989) 145-148.
29. [29] Shih, Epilepsy Res. 7 (1990) 105-116.
30. [30] Sparenborg et al., Neuropharmacolgy 31 (1992) 357-368.
31. [31] Lallement et al., Brain Res. 618 (1993) 227-237.
32. [32] McDonough and Shih, Pharmacol. Biochem. Behav. 51 (1995) 51, in press.